MCF Advisors’s Oyster Point Pharma, Inc. Common Stock OYST Stock Holding History

MCF Advisors’s Portfolio OYST Stock Details OYST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-1,072	Closed	-$5K	–	889
2022 Q2	$5K	Hold	1,072	–	–	﹤0.01%	563
2022 Q1	$12K	Buy	+1,072	New	+$12.8K	﹤0.01%	514
2021 Q4	–	Sell	-1,072	Closed	-$13K	–	753
2021 Q3	$13K	Hold	1,072	–	–	﹤0.01%	464
2021 Q2	$18K	Hold	1,072	–	–	﹤0.01%	399
2021 Q1	$20K	Hold	1,072	–	–	﹤0.01%	367
2020 Q4	$20K	Sell	1,072 -7,060	-87%	-$152K	﹤0.01%	341
2020 Q3	$172K	Hold	8,132	–	–	0.02%	152
2020 Q2	$235K	Sell	8,132 -11,868	-59%	-$358K	0.03%	123
2020 Q1	$700K	Buy	+20,000	New	+$647K	0.12%	52

Other funds holding OYST

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

IFA

Invus Financial Advisors New York $89.2M AUM 10.79% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

PBA

Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return

KKRC

Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return

TAM

Telemark Asset Management Boston, Massachusetts $1.08B AUM 70.88% 1-Year Est. Return

GKIM

GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return

CAC

Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

MCF Advisors's OYST Position: Q3 2022 in Review

MCF Advisors sold out of Oyster Point Pharma, Inc. Common Stock (OYST) in Q3 2022, closing a stake of 1,072 shares — an estimated $5K sold.

MCF Advisors first reported a position in OYST in Q1 2020 and held it in 9 quarters. The position peaked at $700K in Q1 2020. 60 funds tracked by Wall St. Rank hold OYST as of Q3 2022.

MCF Advisors reported no remaining Oyster Point Pharma, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
MCF Advisors sold 1,072 Oyster Point Pharma, Inc. Common Stock shares in Q3 2022, an estimated $5K.
MCF Advisors first reported a position in Oyster Point Pharma, Inc. Common Stock in Q1 2020 and held it in 9 quarters.
MCF Advisors's Oyster Point Pharma, Inc. Common Stock position peaked at $700K in Q1 2020.
60 funds tracked by Wall St. Rank held Oyster Point Pharma, Inc. Common Stock as of Q3 2022.

Based on MCF Advisors's 13F filing for Q3 2022, filed 9 Nov 2022.